Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer

• Päätekijät: Jing Wang (Tekijä), Yan Zhang (Tekijä), GuangPeng Zhang (Tekijä), Li Xiang (Tekijä), HaoWen Pang (Tekijä), Kang Xiong (Tekijä), Yun Lu (Tekijä), JianMei Li (Tekijä), Jie Dai (Tekijä), Sheng Lin (Tekijä), ShaoZhi Fu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Chemotherapy is the primary treatment for advanced non-small-cell lung cancer (NSCLC). However, related dose-dependent toxicity limits its clinical use. Therefore, it is necessary to explore new strategies for improving the clinical outcomes while reducing the side effects of chemotherapy in the tre...